Skip to main content

Table 1 Baseline characteristics of patients

From: Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit

Variables 296 patients
Age (years) 62 (53–70)
Male gender 196 (66 %)
Underlying malignancies
 Hematologic malignancies 242 (81.7 %)
  Acute leukemia 99 (33.4 %)
  Lymphoma 96 (32.4 %)
  Multiple myeloma 28 (9.4 %)
  Miscellaneous 19 (6.4 %)
 Solid tumors 54 (18.3 %)
  Uro-genital 17 (5.7 %)
  Digestive 15 (5 %)
  Pulmonary 9 (3 %)
  Breast 6 (2 %)
  Bone and cartilage 4 (1.3 %)
  Head and neck 4 (1.3 %)
Hematopoietic stem cell transplantation 42 (14.2 %)
Other comorbidities
 Chronic heart failure 61 (20.6 %)
 Chronic liver disease 13 (4.4 %)
 Chronic and end-stage renal failure 13 (4.4 %)
 Human immunodeficiency virus infection 6 (2 %)
 Solid organ transplantation 1 (0.3 %)
Anticoagulant and antiplatelet medications 69 (23.3 %)
 Prophylactic anticoagulant 21 (7.1 %)
 Curative anticoagulant 27 (9.1 %)
 Antiplatelet 21 (7.1 %)
Mechanisms of central thrombocytopenia
 Chemo- or radiotherapy-induced 223 (75.3 %)
 Bone marrow infiltration by malignant cells 55 (18.5 %)
 Hemophagocytosis 10 (3.4 %)
 Drug-induced (allergic) 4 (1.3 %)
 Myelofibrosis 4 (1.3 %)
  1. Variables are expressed as median (interquartile range) or number (percentage)